Author:
Cauley Jane A.,Norton Larry,Lippman Marc E.,Eckert Stephen,Krueger Kathryn A.,Purdie David W.,Farrerons Jordi,Karasik Avraham,Mellstrom Dan,Ng Kong Wah,Stepan Jan J.,Powles Trevor J.,Morrow Monica,Costa Alberto,Silfen Sheryl L.,Walls Erin L.,Schmitt Henry,Muchmore Douglas B.,Jordan V. Craig
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388, 1998
2. Barakat RR: Tamoxifen and the endometrium. Cancer Treat Res 94: 195-207, 1998
3. Cohen FJ, Watts S, Shah A, Akers R, Plouffe L: Uterine effects of three-year raloxifene therapy in postmenopausal women under age 60. Obstet Gynecol 95: 104-110, 2000
4. Cummings S, Eckert S, Krueger K, Grady D, Powles T, Cauley J, Norton L, Nickelsen T, Bjarnason N, Morrow M, Lippman M, Black D, Glusman J, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women. JAMA 281: 2189-2197, 1999
5. National Institutes of Health, Office of Cancer Communications: Publication of the MORE Trial Results Support Study of Tamoxifen and Raloxifene (STAR). Press Release of National Cancer Institute, 1999
Cited by
570 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献